ADA Deficiency
Adenosine Deaminase, Erythrocyte
Test
Aliases/Synonyms
Method
Kinetic Spectrophotometry
Specimens
Whole Blood
Clinical Utility
Adenosine Deaminase (ADA) deficiency is an autosomal recessive disorder of purine metabolism primarily affecting lymphocyte development, viability, and function. Affected individuals have less than 1 percent of normal ADA catalytic activity in red cell hemolysates. ADA deficiency is the cause of 20-30 percent of SCID cases. If the patient has been recently transfused, ADA deficiency may be masked; interpret results with caution. Heterozygotes cannot be identified by this test.
Test Location
Quest Diagnostics, California USA
Test Version
24-Jun-2022
Specimen
Specimens
Whole Blood
Collection Containers
Lavender top (EDTA); Pink top (EDTA); Green top (Li heparin)
Sample Volume
1.0 mL
Minimum Volume
1.0 mL
Collection & Handling
Handling Information
Store and send cold; do not freeze.
Stability
Ambient | 15 days |
---|---|
Refrigerated | 15 days |
Frozen | Not acceptable |
Rejection Criteria
Hemolysis | Present |
---|---|
Specimen | Frozen |
Test Version
24-Jun-2022
Performance / Interpretation
Method
Kinetic Spectrophotometry
Turnaround Time
10 days
Results
Name | Units | Reference Range | Conversion Factor | |
---|---|---|---|---|
Adenosine Deaminase | mU/g Hb |
|
||
Test Location
Quest Diagnostics, California USA
Test Version
24-Jun-2022
Interface / Setup
HL7 Interface Codes
Order Code | Result Codes | Units |
---|---|---|
ADA ERC | 63375ADENOSINE DEAMINASE RBC | mU/g Hb |
Test Version
24-Jun-2022